OncoVV‑shHSP70, a vaccinia virus silencing HSP70, demonstrated potent antitumor efficacy in colorectal cancer cell lines, as well as in syngeneic, xenograft, and humanized mouse models. In cell lines, oncoVV‑shHSP70 promoted viral oncolysis and cytokine production through a self‑reinforcing cycle of ROS‑autophagy. In both CT26 and SW620‑humanized mouse
Rentao Yuan +8 more
wiley +1 more source
Distinct age-related effects of homologous recombination deficiency on genomic profiling and treatment efficacy in gastric cancer. [PDF]
Maki Y +11 more
europepmc +1 more source
In patients with mCSPC treated with apalutamide plus ADT, baseline ctDNA predicted earlier progression to CRPC and worse overall survival. Exploratory genome‐wide analysis identified 12 SNPs associated with apalutamide‐related skin rash. ABSTRACT Despite promising evidence of the efficacy of the androgen deprivation therapy (ADT) plus apalutamide in ...
Masaki Shiota +8 more
wiley +1 more source
Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution. [PDF]
Pepe F +17 more
europepmc +1 more source
SOX30 Governs Synaptonemal Complex Assembly and Homologous Recombination in Male Meiosis
The transcription factor SOX30 directly binds promoter regions of SYCE1 and SYCE2 to mediate their transcriptional activation, thereby enabling proper assembly of central elements within the synaptonemal complex. Structural destabilisation of the synaptonemal complex in Sox30 KK spermatocytes triggers synaptic discontinuity, impairs homologous ...
Kangle Liu +16 more
wiley +1 more source
Genomic and transcriptomic data reveal molecular differences between homologous recombination deficiency subgroups in Chinese ovarian cancer patients. [PDF]
Wang H +14 more
europepmc +1 more source
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data. [PDF]
Zhu R +12 more
europepmc +1 more source
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancers. [PDF]
Doberstein K +11 more
europepmc +1 more source
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer. [PDF]
Christinat Y +16 more
europepmc +1 more source
Combination of <i>BRCA</i> deep targeted sequencing and shallow whole genome sequencing to detect homologous recombination deficiency in ovarian cancer. [PDF]
Nguyen Hoang TP +12 more
europepmc +1 more source

